Annual Current Assets
$194.24 M
+$70.11 M+56.48%
December 31, 2023
Summary
- As of February 26, 2025, TCRX annual total current assets is $194.24 million, with the most recent change of +$70.11 million (+56.48%) on December 31, 2023.
- During the last 3 years, TCRX annual current assets has risen by +$157.79 million (+432.96%).
- TCRX annual current assets is now at all-time high.
Performance
TCRX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$274.08 M
-$25.45 M-8.49%
September 30, 2024
Summary
- As of February 26, 2025, TCRX quarterly total current assets is $274.08 million, with the most recent change of -$25.45 million (-8.49%) on September 30, 2024.
- Over the past year, TCRX quarterly current assets has increased by +$56.52 million (+25.98%).
- TCRX quarterly current assets is now -8.49% below its all-time high of $299.53 million, reached on June 30, 2024.
Performance
TCRX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
TCRX Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +56.5% | +26.0% |
| 3 y3 years | +433.0% | +26.0% |
| 5 y5 years | +358.3% | +26.0% |
TCRX Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +56.5% | -8.5% | +171.6% |
| 5 y | 5-year | at high | +433.0% | -8.5% | +652.0% |
| alltime | all time | at high | +433.0% | -8.5% | +652.0% |
TScan Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $274.08 M(-8.5%) |
| Jun 2024 | - | $299.53 M(+81.8%) |
| Mar 2024 | - | $164.72 M(-15.2%) |
| Dec 2023 | $77.91 M(+3.9%) | $194.24 M(-10.7%) |
| Sep 2023 | - | $217.57 M(-10.2%) |
| Jun 2023 | - | $242.22 M(+140.0%) |
| Mar 2023 | - | $100.91 M(-18.7%) |
| Dec 2022 | $74.96 M | $124.13 M(-12.1%) |
| Sep 2022 | - | $141.18 M(+9.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $129.36 M(-11.2%) |
| Mar 2022 | - | $145.75 M(-12.0%) |
| Dec 2021 | $22.45 M(+68.9%) | $165.65 M(-11.4%) |
| Sep 2021 | - | $187.00 M(+69.9%) |
| Jun 2021 | - | $110.07 M(-11.1%) |
| Mar 2021 | - | $123.87 M(+239.9%) |
| Dec 2020 | $13.29 M(+89.8%) | - |
| Dec 2020 | - | $36.45 M |
| Dec 2019 | $7.00 M | - |
FAQ
- What is TScan Therapeutics annual total current assets?
- What is the all time high annual current assets for TScan Therapeutics?
- What is TScan Therapeutics annual current assets year-on-year change?
- What is TScan Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for TScan Therapeutics?
- What is TScan Therapeutics quarterly current assets year-on-year change?
What is TScan Therapeutics annual total current assets?
The current annual current assets of TCRX is $194.24 M
What is the all time high annual current assets for TScan Therapeutics?
TScan Therapeutics all-time high annual total current assets is $194.24 M
What is TScan Therapeutics annual current assets year-on-year change?
Over the past year, TCRX annual total current assets has changed by +$70.11 M (+56.48%)
What is TScan Therapeutics quarterly total current assets?
The current quarterly current assets of TCRX is $274.08 M
What is the all time high quarterly current assets for TScan Therapeutics?
TScan Therapeutics all-time high quarterly total current assets is $299.53 M
What is TScan Therapeutics quarterly current assets year-on-year change?
Over the past year, TCRX quarterly total current assets has changed by +$56.52 M (+25.98%)